The biological framework of Alzheimer’s disease (AD) recognizes beta-amyloid (Aβ), tau, and neurodegeneration as the characteristic biomarkers in disease pathogenesis [1]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.